Medeon Biodesign Cash Flow Reinvestment Rate
Medeon Biodesign cash flow reinvestment rate. Medeon Biodesign (6499) has a Cash Flow Reinvestment Rate of 5.77x as of March 2022, reinvesting NT$350.52 Million (capex NT$41.12 Million plus investments NT$309.40 Million) from operating cash flow of NT$60.74 Million. See 6499 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Medeon Biodesign (2018–2018)
Cash flow reinvestment rate of Medeon Biodesign from 2018 to 2018. Historical reinvestment intensity for Medeon Biodesign across 1 annual periods. Explore cash flow to debt ratio of Medeon Biodesign to assess how comfortably operating cash covers total debt obligations.
Medeon Biodesign Cash Flow Reinvestment Rate by Year (2018–2018)
Medeon Biodesign cash flow reinvestment rate by year from 2018 to 2018. Year-by-year capital reinvestment analysis for Medeon Biodesign. For the full cash flow conversion analysis, see cash efficiency ratio of Medeon Biodesign.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2018 | 0.96x | NT$310.54 Million | NT$322.05 Million | NT$51.14 Million | — |